Close Menu

Maryland Governor Martin O'Malley announced an initiative to invest $1.1 billion in the state's bioscience industry. Over the next decade, he sees the money going toward tax credits, supporting start-ups, and funding stem cell research. O'Malley also wants to create a Maryland Biotechnology Center to accommodate academic, private, and state ventures. "These are not flash-in-the pan investments," says O'Malley, according to the Washington Post.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.